Cargando…
Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data
To provide initial data on local SARS-CoV-2 epidemiology and spread in indigenous communities in north-eastern Colombia, respiratory swabs and serum samples from volunteers of indigenous communities were examined in March and April 2021. Samples from non-indigenous Colombians from the same villages...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539650/ https://www.ncbi.nlm.nih.gov/pubmed/34696227 http://dx.doi.org/10.3390/vaccines9101120 |
_version_ | 1784588798374445056 |
---|---|
author | Concha, Gustavo Frickmann, Hagen Oey, Anke Strengert, Monika Kreienbrock, Lothar Kann, Simone |
author_facet | Concha, Gustavo Frickmann, Hagen Oey, Anke Strengert, Monika Kreienbrock, Lothar Kann, Simone |
author_sort | Concha, Gustavo |
collection | PubMed |
description | To provide initial data on local SARS-CoV-2 epidemiology and spread in indigenous communities in north-eastern Colombia, respiratory swabs and serum samples from volunteers of indigenous communities were examined in March and April 2021. Samples from non-indigenous Colombians from the same villages were included as well. While previous exposure to SARS-CoV-2 was assessed by analysing serum samples for IgG and IgM with a rapid antibody point-of-care-test (POCT), screening for active infections was carried out with an antigen POCT test and real-time PCR from nasal swabs. In 380 indigenous and 72 non-indigenous volunteers, 61 (13.5%) active infections and an additional 113 (25%) previous infections were identified using diagnostic serology and molecular assays. Previous infections were more frequent in non-indigenous volunteers, and relevant associations of clinical features with active or previous SARS-CoV-2 infections were not observed. Symptoms reported were mild to moderate. SARS-CoV-2 was frequent in the assessed Colombian indigenous communities, as 38.5% of the study participants showed signs of exposure to SARS-CoV-2, which confirms the need to include these indigenous communities in screening and vaccination programs. |
format | Online Article Text |
id | pubmed-8539650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85396502021-10-24 Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data Concha, Gustavo Frickmann, Hagen Oey, Anke Strengert, Monika Kreienbrock, Lothar Kann, Simone Vaccines (Basel) Article To provide initial data on local SARS-CoV-2 epidemiology and spread in indigenous communities in north-eastern Colombia, respiratory swabs and serum samples from volunteers of indigenous communities were examined in March and April 2021. Samples from non-indigenous Colombians from the same villages were included as well. While previous exposure to SARS-CoV-2 was assessed by analysing serum samples for IgG and IgM with a rapid antibody point-of-care-test (POCT), screening for active infections was carried out with an antigen POCT test and real-time PCR from nasal swabs. In 380 indigenous and 72 non-indigenous volunteers, 61 (13.5%) active infections and an additional 113 (25%) previous infections were identified using diagnostic serology and molecular assays. Previous infections were more frequent in non-indigenous volunteers, and relevant associations of clinical features with active or previous SARS-CoV-2 infections were not observed. Symptoms reported were mild to moderate. SARS-CoV-2 was frequent in the assessed Colombian indigenous communities, as 38.5% of the study participants showed signs of exposure to SARS-CoV-2, which confirms the need to include these indigenous communities in screening and vaccination programs. MDPI 2021-10-01 /pmc/articles/PMC8539650/ /pubmed/34696227 http://dx.doi.org/10.3390/vaccines9101120 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Concha, Gustavo Frickmann, Hagen Oey, Anke Strengert, Monika Kreienbrock, Lothar Kann, Simone Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data |
title | Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data |
title_full | Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data |
title_fullStr | Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data |
title_full_unstemmed | Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data |
title_short | Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia—A Cross-Sectional Assessment Providing Preliminary Surveillance Data |
title_sort | direct and indirect proof of sars-cov-2 infections in indigenous wiwa communities in north-eastern colombia—a cross-sectional assessment providing preliminary surveillance data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539650/ https://www.ncbi.nlm.nih.gov/pubmed/34696227 http://dx.doi.org/10.3390/vaccines9101120 |
work_keys_str_mv | AT conchagustavo directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata AT frickmannhagen directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata AT oeyanke directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata AT strengertmonika directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata AT kreienbrocklothar directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata AT kannsimone directandindirectproofofsarscov2infectionsinindigenouswiwacommunitiesinnortheasterncolombiaacrosssectionalassessmentprovidingpreliminarysurveillancedata |